Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

CLL Next Generation Reversible BTK Inhibitor, For Overcoming Acquired Resistance to Irreversible BTK Inhibitors

289 views
November 5, 2018
Oral Abstract CLL 200: LOXO-305
Comments 0
Login to view comments. Click here to Login